Tonix Pharmaceuticals Holding Corp (TNXP)
0.7338
0.00 (0.00%)
USD |
NASDAQ |
Jul 02, 16:00
0.7445
+0.01
(+1.46%)
After-Hours: 20:00
Tonix Pharmaceuticals Research and Development Expense (TTM): 73.01M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 73.01M |
| December 31, 2023 | 86.66M |
| September 30, 2023 | 94.21M |
| June 30, 2023 | 95.36M |
| March 31, 2023 | 89.96M |
| December 31, 2022 | 81.88M |
| September 30, 2022 | 79.50M |
| June 30, 2022 | 70.38M |
| March 31, 2022 | 71.93M |
| December 31, 2021 | 68.84M |
| September 30, 2021 | 58.64M |
| June 30, 2021 | 54.37M |
| March 31, 2021 | 46.81M |
| December 31, 2020 | 36.16M |
| September 30, 2020 | 29.75M |
| June 30, 2020 | 25.99M |
| March 31, 2020 | 18.97M |
| December 31, 2019 | 18.19M |
| September 30, 2019 | 17.56M |
| June 30, 2019 | 15.77M |
| March 31, 2019 | 16.28M |
| December 31, 2018 | 17.56M |
| September 30, 2018 | 16.14M |
| June 30, 2018 | 16.78M |
| March 31, 2018 | 15.52M |
| Date | Value |
|---|---|
| December 31, 2017 | 13.34M |
| September 30, 2017 | 14.59M |
| June 30, 2017 | 16.15M |
| March 31, 2017 | 20.86M |
| December 31, 2016 | 28.53M |
| September 30, 2016 | 33.14M |
| June 30, 2016 | 37.99M |
| March 31, 2016 | 39.35M |
| December 31, 2015 | 35.50M |
| September 30, 2015 | 31.79M |
| June 30, 2015 | 26.69M |
| March 31, 2015 | 21.90M |
| December 31, 2014 | 18.62M |
| September 30, 2014 | 14.17M |
| June 30, 2014 | 10.59M |
| March 31, 2014 | 7.459M |
| December 31, 2013 | 4.65M |
| September 30, 2013 | 4.022M |
| June 30, 2013 | 3.044M |
| March 31, 2013 | 2.927M |
| December 31, 2012 | 2.584M |
| September 30, 2012 | 2.407M |
| June 30, 2012 | 2.241M |
| March 31, 2012 | 1.476M |
| December 31, 2011 | 1.158M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
17.56M
Minimum
Sep 2019
95.36M
Maximum
Jun 2023
58.85M
Average
68.84M
Median
Dec 2021
Research and Development Expense (TTM) Benchmarks
| ThermoGenesis Holdings Inc | 1.189M |
| Assure Holdings Corp | -- |
| Vigil Neuroscience Inc | 61.43M |
| Allakos Inc | 152.65M |
| RAPT Therapeutics Inc | 100.21M |